MK2 Promotes the Development and Progression of Pancreatic Neuroendocrine Tumors Mediated by Macrophages and Metabolomic Factors
Cases of pancreatic neuroendocrine tumors (PNETs) are growing in number, and new treatment options are needed in order to improve patient outcomes. The mitogen-activated protein kinase-activated protein kinase 2 (MK2) is a crucial regulator of cytokine/chemokine production. The significance of MK2 e...
Main Authors: | Damian Jacenik, Eric J. Lebish, Ellen J. Beswick |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/21/13561 |
Similar Items
-
MK2 drives progression of pancreas and colon cancers by suppressing CD8+ T cell cytotoxic function and is a potential immunotherapy target
by: Damian Jacenik, et al.
Published: (2023-06-01) -
MK2 Inhibitors as a Potential Crohn’s Disease Treatment Approach for Regulating MMP Expression, Cleavage of Checkpoint Molecules and T Cell Activity
by: Eric J. Lebish, et al.
Published: (2022-12-01) -
Treatment Options for Pancreatic Neuroendocrine Tumors
by: Amit Akirov, et al.
Published: (2019-06-01) -
PANCREATIC NEUROENDOCRINE TUMORS: SURGICAL RESECTION
by: Marcos BELOTTO, et al.
Published: (2019-02-01) -
Nondegenerated cystic neuroendocrine tumor of the pancreas: a case report
by: Keisuke Noda, et al.
Published: (2020-06-01)